Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 15.14% is 70% above its 5-year average of 8.92%, around the middle of its 5-year range (0.00%–21.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.94% below its 12-month average of 16.81%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.14%.
DEBT TO ASSETS RATIO
15.14%
DEBT TO ASSETS RATIO AVG TTM
16.81%
DEBT TO ASSETS RATIO AVG 3Y
15.31%
DEBT TO ASSETS RATIO AVG 5Y
8.92%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.94%
CURRENT VS 3Y AVG
-1.13%
CURRENT VS 5Y AVG
+69.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
+15037.38%
vs the sector median at left
Pliant Therapeutics, Inc.
Market Cap
$63.78M
Debt to Assets Ratio
15.14%
TTM Avg
16.81%
3Y Avg
15.31%
5Y Avg
8.92%
Market Cap
$63.69M
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$62.54M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $63.78M | 15.14% | 16.81% | 15.31% | 8.92% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.69M | 0.59% | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.61M | 0.27% | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.08% | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $62.54M | 0.01% | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.57M | 0.51% | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $66.00M | 0.19% | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $61.14M | 0.09% | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $66.45M | 0.02% | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.62M | 0.01% | N/A | N/A | N/A |
Debt/Assets
15.1%
Debt/Equity
0.20
Current Ratio
9.90
Interest Coverage
-58.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 15.14% |
| 2026-03-31 | 14.21% |
| 2025-12-31 | 12.92% |
| 2025-09-30 | 21.64% |
| 2025-06-30 | 20.14% |
| 2025-03-31 | 17.45% |
| 2024-12-31 | 15.16% |
| 2024-09-30 | 13.51% |
| 2024-06-30 | 12.45% |
| 2024-03-31 | 10.48% |
| 2023-12-31 | 2.22% |
| 2023-09-30 | 2.24% |
| 2023-06-30 | 2.53% |
| 2023-03-31 | 2.54% |
| 2022-12-31 | 4.51% |
| 2022-09-30 | 4.42% |
| 2022-06-30 | 8.84% |
| 2022-03-31 | 3.51% |
| 2021-12-31 | 3.25% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.10% |
| 2021-03-31 | 0.10% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.12% |
| 2020-06-30 | 0.12% |
| 2020-03-31 | 0.23% |
| 2019-12-31 | 0.37% |
| 2019-03-31 | 0.00% |
